Chang YS, Park WS. Strategies to overcome the limit of viability of microprimie. Neonatal Med 2013;20(3):258-67.
American Academy of Pediatrics Committee on Nutrition. Nutritional needs of low-birth-weight infants. Pediatrics 1985;75(5):976-86.
Chang YS. Nutritional support in premature infants. Hanyang Med Rev 2011;31(4):246-53.
Lapillonne A, Griffin IJ. Feeding preterm infants today for later metabolic and cardiovascular outcomes. J Pediatr 2013;162(3 Suppl):S7-16.
Stephens BE, Walden RV, Gargus RA, Tucker R, McKinley L, Mance M, et al. First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants. Pediatrics 2009;123(5):1337-43.
Denne SC, Karn CA, Wang J, Liechty EA. Effect of intravenous glucose and lipid on proteolysis and glucose production in normal newborns. Am J Physiol 1995;269(2 Pt 1):E361-7.
Thureen PJ, Hay WW. Neonatal nutrition and metabolism. 2nd ed. Cambridge:Cambridge University Press;2006.
Ziegler EE, O'Donnell AM, Nelson SE, Fomon SJ. Body composition of the reference fetus. Growth 1976;40(4):329-41.
Denne SC, Poindexter BB. Evidence supporting early nutritional support with parenteral amino acid infusion. Semin Perinatol 2007;31(2):56-60.
Van Goudoever JB, Colen T, Wattimena JL, Huijmans JG, Carnielli VP, Sauer PJ. Immediate commencement of amino acid supplementation in preterm infants: effect on serum amino acid concentrations and protein kinetics on the first day of life. J Pediatr 1995;127(3):458-65.
Rivera A Jr, Bell EF, Bier DM. Effect of intravenous amino acids on protein metabolism of preterm infants during the first three days of life. Pediatr Res 1993;33(2):106-11.
Thureen PJ, Melara D, Fennessey PV, Hay WW Jr. Effect of low versus high intravenous amino acid intake on very low birth weight infants in the early neonatal period. Pediatr Res 2003;53(1):24-32.
Van den Akker CH, Van Goudoever JB. Recent advances in our understanding of protein and amino acid metabolism in the human fetus. Curr Opin Clin Nutr Metab Care 2010;13(1):75-80.
te Braake FW, van den Akker CH, Wattimena DJ, Huijmans JG, van Goudoever JB. Amino acid administration to premature infants directly after birth. J Pediatr 2005;147(4):457-61.
Hans DM, Pylipow M, Long JD, Thureen PJ, Georgieff MK. Nutritional practices in the neonatal intensive care unit: analysis of a 2006 neonatal nutrition survey. Pediatrics 2009;123(1):51-7.
Bonsante F, Iacobelli S, Latorre G, Rigo J, De Felice C, Robillard PY, et al. Initial amino acid intake influences phosphorus and calcium homeostasis in preterm infants--it is time to change the composition of the early parenteral nutrition. PLoS One 2013;8(8):e72880.
Ichikawa G, Watabe Y, Suzumura H, Sairenchi T, Muto T, Arisaka O. Hypophosphatemia in small for gestational age extremely low birth weight infants receiving parenteral nutrition in the first week after birth. J Pediatr Endocrinol Metab 2012;25(3-4):317-21.
Moltu SJ, Strømmen K, Blakstad EW, Almaas AN, Westerberg AC, Brække K, et al. Enhanced feeding in very-low-birth-weight infants may cause electrolyte disturbances and septicemia--a randomized, controlled trial. Clin Nutr 2013;32(2):207-12.
Mizumoto H, Mikami M, Oda H, Hata D. Refeeding syndrome in a small-for-dates micro-preemie receiving early parenteral nutrition. Pediatr Int 2012;54:715-7.
Merritt R, DeLegge MH, Holcombe B, Mueller C, Ochoa J, Smith KR, et al. The A.S.P.E.N. nutrition support practice manual guide. 2nd ed. Silver Spring:American Society for Parenteral and Enteral Nutrition;2005.
Ridout E, Melara D, Rottinghaus S, Thureen PJ. Blood urea nitrogen concentration as a marker of amino-acid intolerance in neonates with birthweight less than 1250 g. J Perinatol 2005;25(2):130-3.
G?bel Y, Koletzko B, B?hles HJ, Engelsberger I, Forget D, Le Brun A, et al. Parenteral fat emulsions based on olive and soybean oils: a randomized clinical trial in preterm infants. J Pediatr Gastroenterol Nutr 2003;37(2):161-7.
Rubin M, Harell D, Naor N, Moser A, Wielunsky E, Merlob P, et al. Lipid infusion with different triglyceride cores (long-chain vs medium-chain/long-chain triglycerides): effect on plasma lipids and bilirubin binding in premature infants. JPEN J Parenter Enteral Nutr 1991;15(6):642-6.
Socha P, Koletzko B, Demmelmair H, Jankowska I, Stajniak A, Bednarska-Makaruk M, et al. Short-term effects of parenteral nutrition of cholestatic infants with lipid emulsions based on medium-chain and long-chain triacylglycerols. Nutrition 2007;23(2):121-6.
Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008;121(3):e678-86.
Rayyan M, Devlieger H, Jochum F, Allegaert K. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil:a randomized double-blind study in preterm infants. JPEN J Parenter Enteral Nutr 2012;36(1 Suppl):81S-94S.
Kim MJ, Bae HJ, Cho YS, Kim KS, Kim HS, Lee HS, et al. Effects of SMOFlipid on prophylaxis of cholestasis in premature very low birth weight infants. JKSPEN 2013;5(2):67-75.
Kerner JA Jr, Poole RL. The use of IV fat in neonates. Nutr Clin Pract 2006;21(4):374-80.
Valentine CJ, Puthoff TD. Enhancing parenteral nutrition therapy for the neonate. Nutr Clin Pract 2007;22(2):183-93.
Denne SC, Kalhan SC. Glucose carbon recycling and oxidation in human newborns. Am J Physiol 1986;251(1 Pt 1):E71-7.
Hertz DE, Karn CA, Liu YM, Liechty EA, Denne SC. Intravenous glucose suppresses glucose production but not proteolysis in extremely premature newborns. J Clin Invest 1993;92(4):1752-8.
Sunehag AL, Haymond MW. Glucose extremes in newborn infants. Clin Perinatol 2002;29(2):245-60.
Mitanchez D. Glucose regulation in preterm newborn infants. Horm Res 2007;68(6):265-71.
Hay WW Jr. Strategies for feeding the preterm infant. Neonatology 2008;94(4):245-54.
Langdon DR, Stanley CA, Sperling MA. Hypoglycemia in the infant and child. In: Sperling M, ed. Pediatric endocrinology. 3rd ed. Philadelphia:Saunders Elsevier;2008:422-3.
Hays SP, Smith EO, Sunehag AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics 2006;118(5):1811-8.
Cowett RM, Farrag HM. Selected principles of perinatalneonatal glucose metabolism. Semin Neonatol 2004;9(1):37-47.
Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Ahluwalia JS, Vanhole C, Palmer C, et al. A randomised controlled trial of early insulin therapy in very low birth weight infants, "NIRTURE"(neonatal insulin replacement therapy in Europe). BMC Pediatr 2007;7:29.
Hey E. Hyperglycaemia and the very preterm baby. Semin Fetal Neonatal Med 2005;10(4):377-87.
Kairamkonda VR, Khashu M. Controversies in the management of hyperglycemia in the ELBW infant. Indian Pediatr 2008;45(1):29-38.
Yoo HS, Ahn SY, Lee MS, Han YM, Sung SI, Chang YS, et al. Permissive hyperglycemia in extremely low birth weight infants. J Korean Med Sci 2013;28(3):450-60.
Ditzenberger GR, Collins SD, Binder N. Continuous insulin intravenous infusion therapy for VLBW infants. J Perinat Neonatal Nurs 1999;13(3):70-82.
Poindexter BB, Karn CA, Denne SC. Exogenous insulin reduces proteolysis and protein synthesis in extremely low birth weight infants. J Pediatr 1998;132(6):948-53.